Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Takara Bio Inc

+ Add to Watchlist

4974:JP

1,379.0 JPY 7.0 0.51%

As of 01:00:00 ET on 03/04/2015.

Snapshot for Takara Bio Inc (4974)

Open: 1,381.0 Day's Range: 1,366.0 - 1,397.0 Volume: 214,600
Previous Close: 1,386.0 52wk Range: 995.0 - 1,995.0 1-Yr Rtn: -18.09%

Stock Chart for 4974

No chart data available.
  • 4974:JP 1,378.0
  • 1D
  • 1M
  • 1Y
1,386.0
Interactive 4974 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4974

Current P/E Ratio (ttm) 196.8594
Estimated P/E(03/2015) 126.1319
Relative P/E vs. TPX 11.2802
Earnings Per Share (JPY) (ttm) 7.0050
Est. EPS (JPY) (03/2015) 10.9330
Est. PEG Ratio -
Market Cap (M JPY) 166,053.11
Shares Outstanding (M) 120.42
30 Day Average Volume 213,733
Price/Book (mrq) 2.8999
Price/Sale (ttm) 6.6286
Dividend Indicated Gross Yield 0.09%
Cash Dividend (JPY) 1.2000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4974

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4974

TAKARA BIO INC. is a biopharmaceutical company. The Company researches and develops reagents for genome engineering and analysis, technology used for gene therapy, and natural health food products using mushrooms and seaweed body and extracts.

Hisashi OhmiyaChairmanKoichi NakaoPresident
Kazuto TakesakoSenior Managing DirectorShuichiro MatsuzakiSenior Managing Director
More Company Profile & Key Executives for 4974

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil